首页>
外国专利>
Mumps virus attenuation method, mumps virus, and live vaccine
Mumps virus attenuation method, mumps virus, and live vaccine
展开▼
机译:腮腺炎病毒减毒方法,腮腺炎病毒和活疫苗
展开▼
页面导航
摘要
著录项
相似文献
摘要
Provided is a mumps live vaccine having reduced CNS pathogenicity while maintaining efficacy by using a reliable technique for introducing an miRNA complementary sequence rather than unreliable production by subculture. The primary target tissue of MuV in the central nervous system was discovered to be choroid plexus ependymal cells present on the surface of the inside of the cerebral ventricles, rather than nerve cells. Incorporating a sequence into the mumps virus that is complementary to the miRNA expressed at a high level in the choroid plexus attenuates the mumps virus. In particular, focusing on the miRNA referred to as "miR449" expressed specifically in the choroid plexus, the present invention is characterized in that at least two connected sequences of ACCAGCTAACAATACACTGCCA or ACCAGCTAACAATACACTGCCA, which are sequences complementary to miR449, are incorporated into the mumps virus.
展开▼